Guide for Authors
The importance of lipids as one of the fundamental classes of biological compounds is well established.
The application of our knowledge of the biochemistry, chemistry and physiology of lipids to biotechnology, the fats and oils industry
and medicine have continued to expand apace. In addition new dimensions such as lipid biophysics, especially with relevance to membranes
and lipoproteins, and basic liposome research and applications have been added. To cope with all these advances in knowledge a journal
is needed to review recent progress in particular fields and to set current research against its historical background.
Progress
in Lipid Research fulfils this role.
Each volume contains up-to-date surveys of special aspects of lipid research. The invited
reviews are comprehensive enough to provide sufficient overview but concentrate on reporting and critically appraising the most recent
data. Subjects are chosen for their timeliness or because major developments have taken place in the last few years. They include methodological
reviews as well as chemical, biochemical and medical articles. All lipid compounds and derivatives are covered, ranging from fatty acids
and other simple molecules, through steroids, terpenoids and phospho- or glycolipids to complex structures such as lipoproteins and biological
membranes. We hope that those whose main interest is in lipid biophysics and liposome research will join as new readers, benefiting from
the journal's classical aspects of lipid metabolism, lipids in signal transduction and lipid enzymology, and that current readers will
benefit from the exposure to top quality research on the new aspects.
Types of paper
Reviews
are by invitation only. Proposals can be submitted to the editors and are welcome. Please submit a short abstract, key figure and rationale
for your review as well as a proposed timeline.
Contact details for submission
Invited papers
should be submitted through the e-submission site
http://ees.elsevier.com/plr. For questions on the submission and reviewing
process, please contact the Editorial Office, Mrs. Andy Deelen at
a.deelen@elsevier.com. For submitting ideas or outlines
of potential new reviews, please select one of the editors.
Page charges
This journal has
no page charges.
Ethics in publishing
For
information on Ethics in publishing and Ethical guidelines for journal publication see
http://www.elsevier.com/publishingethics
and
http://www.elsevier.com/ethicalguidelines.
Policy and ethics
The work
described in your article must have been carried out in accordance with
The Code of Ethics of the World Medical Association (Declaration
of Helsinki) for experiments involving humans http://www.wma.net/en/30publications/10policies/b3/index.html;
EU
Directive 2010/63/EU for animal experiments http://ec.europa.eu/environment/chemicals/lab_animals/legislation_en.htm;
Uniform Requirements for manuscripts submitted to Biomedical journals http://www.icmje.org. This must be stated
at an appropriate point in the article.
Conflict of interest
All authors are requested to
disclose any actual or potential conflict of interest including any financial, personal or other relationships with other people or organizations
within three years of beginning the submitted work that could inappropriately influence, or be perceived to influence, their work. See
also
http://www.elsevier.com/conflictsofinterest.
Submission declaration
Submission
of an article implies that the work described has not been published previously (except in the form of an abstract or as part of a published
lecture or academic thesis), that it is not under consideration for publication elsewhere, that its publication is approved by all authors
and tacitly or explicitly by the responsible authorities where the work was carried out, and that, if accepted, it will not be published
elsewhere including electronically in the same form, in English or in any other language, without the written consent of the copyright-holder.
Authorship
All authors should have made substantial contributions to all of the following: (1) the conception
and design of the study, or acquisition of data, or analysis and interpretation of data, (2) drafting the article or revising it critically
for important intellectual content, (3) final approval of the version to be submitted.
Changes to authorship
This
policy concerns the addition, deletion, or rearrangement of author names in the authorship of accepted manuscripts:
Before the
accepted manuscript is published in an online issue: Requests to add or remove an author, or to rearrange the author names, must
be sent to the Journal Manager from the corresponding author of the accepted manuscript and must include: (a) the reason the name should
be added or removed, or the author names rearranged and (b) written confirmation (e-mail, fax, letter) from all authors that they agree
with the addition, removal or rearrangement. In the case of addition or removal of authors, this includes confirmation from the author
being added or removed. Requests that are not sent by the corresponding author will be forwarded by the Journal Manager to the corresponding
author, who must follow the procedure as described above. Note that: (1) Journal Managers will inform the Journal Editors of any such
requests and (2) publication of the accepted manuscript in an online issue is suspended until authorship has been agreed.
After
the accepted manuscript is published in an online issue: Any requests to add, delete, or rearrange author names in an article published
in an online issue will follow the same policies as noted above and result in a corrigendum.
Copyright
Upon
acceptance of an article, authors will be asked to complete a 'Journal Publishing Agreement' (for more information on this and copyright
see
http://www.elsevier.com/copyright). Acceptance of the agreement will ensure the widest possible dissemination of information.
An e-mail will be sent to the corresponding author confirming receipt of the manuscript together with a 'Journal Publishing Agreement'
form or a link to the online version of this agreement.
Subscribers may reproduce tables of contents or prepare lists of articles
including abstracts for internal circulation within their institutions. Permission of the Publisher is required for resale or distribution
outside the institution and for all other derivative works, including compilations and translations (please consult
http://www.elsevier.com/permissions).
If excerpts from other copyrighted works are included, the author(s) must obtain written permission from the copyright owners and credit
the source(s) in the article. Elsevier has preprinted forms for use by authors in these cases: please consult
http://www.elsevier.com/permissions.
Retained author rights
As an author you (or your employer or institution) retain certain rights; for details
you are referred to:
http://www.elsevier.com/authorsrights.
Role of the funding source
You
are requested to identify who provided financial support for the conduct of the research and/or preparation of the article and to briefly
describe the role of the sponsor(s), if any, in study design; in the collection, analysis and interpretation of data; in the writing
of the report; and in the decision to submit the article for publication. If the funding source(s) had no such involvement then this
should be stated. Please see
http://www.elsevier.com/funding.
Elsevier journals comply with
current NIH public access policy.
Funding body agreements and policies
Elsevier has established
agreements and developed policies to allow authors whose articles appear in journals published by Elsevier, to comply with potential
manuscript archiving requirements as specified as conditions of their grant awards. To learn more about existing agreements and policies
please visit
http://www.elsevier.com/fundingbodies.
Open access
This journal
offers you the option of making your article freely available to all via the ScienceDirect platform. To prevent any conflict of interest,
you can only make this choice after receiving notification that your article has been accepted for publication. The fee of $3,000 excludes
taxes and other potential author fees such as color charges. In some cases, institutions and funding bodies have entered into agreement
with Elsevier to meet these fees on behalf of their authors. Details of these agreements are available at
http://www.elsevier.com/fundingbodies.
Authors of accepted articles, who wish to take advantage of this option, should complete and submit the order form (available at
http://www.elsevier.com/locate/openaccessform.pdf).
Whatever access option you choose, you retain many rights as an author, including the right to post a revised personal version of your
article on your own website. More information can be found here:
http://www.elsevier.com/authorsrights.
Language and language services
Please write your text in good English (American or British usage is accepted,
but not a mixture of these). Authors who require information about language editing and copyediting services pre- and post-submission
please visit
http://webshop.elsevier.com/languageservices
or our customer support site at
http://support.elsevier.com
for more information.
Submission
Submission to this journal proceeds totally online and
you will be guided stepwise through the creation and uploading of your files. The system automatically converts source files to a single
PDF file of the article, which is used in the peer-review process. Please note that even though manuscript source files are converted
to PDF files at submission for the review process, these source files are needed for further processing after acceptance. All correspondence,
including notification of the Editor's decision and requests for revision, takes place by e-mail removing the need for a paper trail.
Please submit your article via
http://ees.elsevier.com/plr.
Referees
Please
submit, with the manuscript, the names, addresses and e-mail addresses of three potential referees. Note that the editor retains the
sole right to decide whether or not the suggested reviewers are used.
Use
of wordprocessing software
It is important that the file be saved in the native format of the wordprocessor used. The text
should be in single-column format. Keep the layout of the text as simple as possible. Most formatting codes will be removed and replaced
on processing the article. In particular, do not use the wordprocessor's options to justify text or to hyphenate words. However, do use
bold face, italics, subscripts, superscripts etc. When preparing tables, if you are using a table grid, use only one grid for each individual
table and not a grid for each row. If no grid is used, use tabs, not spaces, to align columns. The electronic text should be prepared
in a way very similar to that of conventional manuscripts (see also the Guide to Publishing with Elsevier:
http://www.elsevier.com/guidepublication).
Note that source files of figures, tables and text graphics will be required whether or not you embed your figures in the text. See also
the section on Electronic artwork.
To avoid unnecessary errors you are strongly advised to use the 'spell-check' and 'grammar-check'
functions of your wordprocessor.
Article structure
Subdivision - numbered
sections
Divide your article into clearly defined and numbered sections. Subsections should be numbered 1.1 (then 1.1.1,
1.1.2, ...), 1.2, etc. (the abstract is not included in section numbering). Use this numbering also for internal cross-referencing: do
not just refer to 'the text'. Any subsection may be given a brief heading. Each heading should appear on its own separate line.
Title
The title should be short and enticing (ideally eight words or fewer), and should not contain abbreviations.
Please feel free to suggest your own title.
Abstract
All reviews should be prefaced by a
summary of recent advances of 200-250 words. The summary is important: it should contain sufficient information for the reader to be
able to appreciate the relevance of the full review when read alone. Summaries are used by abstracting services and many users of these
services read only the summary. It should include background information and specific examples of recent advances, rather than promises
that a particular subject will be discussed - the scope of the review should instead appear at the end of the introduction. References
should not be included and abbreviations should be avoided as far as possible.
Introduction
The
introduction should be accessible to a wide variety of scientists by avoiding the use of jargon and concepts
Main
text or review
Use concise, logical subheadings to provide clear links between the different sections and guide the reader
Conclusions and perspective
The conclusions section should summarise the topics discussed and describe future
directions, including the
Introduction
State the objectives of the work and provide an adequate
background, avoiding a detailed literature survey or a summary of the results.
Material and methods
Provide
sufficient detail to allow the work to be reproduced. Methods already published should be indicated by a reference: only relevant modifications
should be described.
Theory/calculation
A Theory section should extend, not repeat, the
background to the article already dealt with in the Introduction and lay the foundation for further work. In contrast, a Calculation
section represents a practical development from a theoretical basis.
Results
Results should
be clear and concise.
Discussion
This should explore the significance of the results of
the work, not repeat them. A combined Results and Discussion section is often appropriate. Avoid extensive citations and discussion of
published literature.
Conclusions
The main conclusions of the study may be presented in
a short Conclusions section, which may stand alone or form a subsection of a Discussion or Results and Discussion section.
Appendices
If there is more than one appendix, they should be identified as A, B, etc. Formulae and equations
in appendices should be given separate numbering: Eq. (A.1), Eq. (A.2), etc.; in a subsequent appendix, Eq. (B.1) and so on. Similarly
for tables and figures: Table A.1; Fig. A.1, etc.
Essential title page information
•
Title.
Concise and informative. Titles are often used in information-retrieval systems. Avoid abbreviations and formulae
where possible.
•
Author names and affiliations.
Where the family name may be ambiguous (e.g., a double name),
please indicate this clearly. Present the authors' affiliation addresses (where the actual work was done) below the names. Indicate all
affiliations with a lower-case superscript letter immediately after the author's name and in front of the appropriate address. Provide
the full postal address of each affiliation, including the country name and, if available, the e-mail address of each author.
•
Corresponding author.
Clearly indicate who will handle correspondence at all stages of refereeing and publication, also
post-publication.
Ensure that telephone and fax numbers (with country and area code) are provided in addition to the e-mail address
and the complete postal address. Contact details must be kept up to date by the corresponding author.
•
Present/permanent
address.
If an author has moved since the work described in the article was done, or was visiting at the time, a 'Present address'
(or 'Permanent address') may be indicated as a footnote to that author's name. The address at which the author actually did the work
must be retained as the main, affiliation address. Superscript Arabic numerals are used for such footnotes.
Abstract
A
concise and factual abstract is required. The abstract should state briefly the purpose of the research, the principal results and major
conclusions. An abstract is often presented separately from the article, so it must be able to stand alone. For this reason, References
should be avoided, but if essential, then cite the author(s) and year(s). Also, non-standard or uncommon abbreviations should be avoided,
but if essential they must be defined at their first mention in the abstract itself.
Keywords
Immediately
after the abstract, provide a maximum of 6 keywords, using American spelling and avoiding general and plural terms and multiple concepts
(avoid, for example, 'and', 'of'). Be sparing with abbreviations: only abbreviations firmly established in the field may be eligible.
These keywords will be used for indexing purposes.
Abbreviations
Define abbreviations that
are not standard in this field in a footnote to be placed on the first page of the article. Such abbreviations that are unavoidable in
the abstract must be defined at their first mention there, as well as in the footnote. Ensure consistency of abbreviations throughout
the article.
Acknowledgements
Collate acknowledgements in a separate section at the end
of the article before the references and do not, therefore, include them on the title page, as a footnote to the title or otherwise.
List here those individuals who provided help during the research (e.g., providing language help, writing assistance or proof reading
the article, etc.).
Database linking
Elsevier aims at connecting online articles with external
databases which are useful in their respective research communities. If your article contains relevant unique identifiers or accession
numbers (bioinformatics) linking to information on entities (genes, proteins, diseases, etc.) or structures deposited in public databases,
then please indicate those entities according to the standard explained below.
Authors should explicitly mention the
database
abbreviation (as mentioned below) together with the actual database number, bearing in mind that an error in a letter or number
can result in a dead link in the online version of the article.
Please use the following format:
Database ID: xxxx
Links
can be provided in your online article to the following databases (examples of citations are given in parentheses):
•
ASTM:
ASTM Standards Database (ASTM ID: G63)
•
CCDC: Cambridge Crystallographic
Data Centre (CCDC ID: AI631510)
•
GenBank: Genetic sequence
database at the National Center for Biotechnology Information (NCBI) (GenBank ID: BA123456)
•
GEO:
Gene Expression Omnibus (GEO ID: GSE27196; GEO ID: GPL5366; GEO ID: GSM9853)
•
MI:
EMBL-EBI OLS Molecular Interaction Ontology (MI ID: 0218)
•
MINT:
Molecular INTeractions database (MINT ID: 6166710)
•
NCBI Taxonomy:
NCBI Taxonomy Browser (NCBI Taxonomy ID: 48184)
•
NCT: ClinicalTrials.gov
(NCT ID: NCT00222573)
•
OMIM: Online Mendelian Inheritance
in Man (OMIM ID: 601240)
•
PDB: Worldwide Protein Data
Bank (PDB ID: 1TUP)
•
TAIR: The Arabidopsis Information Resource
database (TAIR ID: AT1G01020)
•
UniProt: Universal Protein Resource
Knowledgebase (UniProt ID: Q9H0H5)
Depositing Novel Lipid Structures in LIPID MAPS Database:
Progress
in Lipid Research recommends that authors of manuscripts deposit all novel lipid molecules for registration in the LIPID MAPS structure
database prior to publication. This will be extremely beneficial in terms of (a): maintaining and expanding a comprehensive lipid database
covering a wide variety of sources (e.g., mammals, plants, fungi, bacteria, marine organisms), (b): accurate classification of new lipid
structures, (c): application of consistent nomenclature standards with regard to systematic names and abbreviations, and (d): consistent
and unambiguous structural representation. The preferred method for depositing lipid structures is a Web-based registration system on
the
LIPID MAPS Web site that will enable authors to enter
lipid structures and accompanying names, synonyms, references, and classification information. During the submission process, structures
are validated for uniqueness using a search on the current database. The submitted structures are then stored in a private, temporary
database where they are reviewed by LIPID MAPS bioinformatics staff prior to being classified, checked for correct nomenclature, and
registered in the public LIPID MAPS structure database. Questions regarding the submission of structures should be directed to
webmaster@lipidmaps.org.
Math formulae
Present simple formulae in the line of normal text where possible and use the solidus (/) instead
of a horizontal line for small fractional terms, e.g., X/Y. In principle, variables are to be presented in italics. Powers of e are often
more conveniently denoted by exp. Number consecutively any equations that have to be displayed separately from the text (if referred
to explicitly in the text).
Footnotes
Footnotes should be used sparingly. Number them consecutively
throughout the article, using superscript Arabic numbers. Many wordprocessors build footnotes into the text, and this feature may be
used. Should this not be the case, indicate the position of footnotes in the text and present the footnotes themselves separately at
the end of the article. Do not include footnotes in the Reference list.
Table footnotes
Indicate each footnote in a
table with a superscript lowercase letter.
Artwork
Image manipulation
Whilst
it is accepted that authors sometimes need to manipulate images for clarity, manipulation for purposes of deception or fraud will be
seen as scientific ethical abuse and will be dealt with accordingly. For graphical images, this journal is applying the following policy:
no specific feature within an image may be enhanced, obscured, moved, removed, or introduced. Adjustments of brightness, contrast, or
color balance are acceptable if and as long as they do not obscure or eliminate any information present in the original. Nonlinear adjustments
(e.g. changes to gamma settings) must be disclosed in the figure legend.
Electronic artwork
General
points
• Make sure you use uniform lettering and sizing of your original artwork.
• Save text in illustrations
as 'graphics' or enclose the font.
• Only use the following fonts in your illustrations: Arial, Courier, Times, Symbol.
•
Number the illustrations according to their sequence in the text.
• Use a logical naming convention for your artwork files.
• Provide captions to illustrations separately.
• Produce images near to the desired size of the printed version.
•
Submit each figure as a separate file.
A detailed guide on electronic artwork is available on our website:
http://www.elsevier.com/artworkinstructions
You are urged to visit this site; some excerpts from the detailed information are given here.
Formats
Regardless
of the application used, when your electronic artwork is finalised, please 'save as' or convert the images to one of the following formats
(note the resolution requirements for line drawings, halftones, and line/halftone combinations given below):
EPS: Vector drawings.
Embed the font or save the text as 'graphics'.
TIFF: Color or grayscale photographs (halftones): always use a minimum of 300 dpi.
TIFF: Bitmapped line drawings: use a minimum of 1000 dpi.
TIFF: Combinations bitmapped line/half-tone (color or grayscale): a
minimum of 500 dpi is required.
If your electronic artwork is created in a Microsoft Office application (Word, PowerPoint, Excel)
then please supply 'as is'.
Please do not:
• Supply files that are optimised for screen use (e.g., GIF, BMP, PICT,
WPG); the resolution is too low;
• Supply files that are too low in resolution;
• Submit graphics that are disproportionately
large for the content.
Color artwork
Please make sure that artwork files are in an acceptable
format (TIFF, EPS or MS Office files) and with the correct resolution. If, together with your accepted article, you submit usable color
figures then Elsevier will ensure, at no additional charge, that these figures will appear in color on the Web (e.g., ScienceDirect and
other sites) regardless of whether or not these illustrations are reproduced in color in the printed version. Color reproduction in print
will be free of charge, provided the figure warrants reproduction in color and a reasonable number is submitted. Please clearly indicate
your preference for color in print or on the Web only, to help us save unnecessary costs. For further information on the preparation
of electronic artwork, please see
http://www.elsevier.com/artworkinstructions Please note: Because of technical complications
which can arise by converting color figures to "gray scale" (for the printed version should you not opt for color in print) please submit
in addition usable black and white versions of all the color illustrations.
Figure captions
Ensure
that each illustration has a caption. Supply captions separately, not attached to the figure. A caption should comprise a brief title
(
not on the figure itself) and a description of the illustration. Keep text in the illustrations themselves to a minimum but explain
all symbols and abbreviations used.
Tables
Number tables consecutively in accordance with
their appearance in the text. Place footnotes to tables below the table body and indicate them with superscript lowercase letters. Avoid
vertical rules. Be sparing in the use of tables and ensure that the data presented in tables do not duplicate results described elsewhere
in the article.
References
Citation in text
Please ensure
that every reference cited in the text is also present in the reference list (and vice versa). Any references cited in the abstract must
be given in full. Unpublished results and personal communications are not recommended in the reference list, but may be mentioned in
the text. If these references are included in the reference list they should follow the standard reference style of the journal and should
include a substitution of the publication date with either 'Unpublished results' or 'Personal communication'. Citation of a reference
as 'in press' implies that the item has been accepted for publication.
Web references
As
a minimum, the full URL should be given and the date when the reference was last accessed. Any further information, if known (DOI, author
names, dates, reference to a source publication, etc.), should also be given. Web references can be listed separately (e.g., after the
reference list) under a different heading if desired, or can be included in the reference list.
Reference
management software
This journal has standard templates available in key reference management packages EndNote (
http://www.endnote.com/support/enstyles.asp)
and Reference Manager (
http://refman.com/support/rmstyles.asp). Using plug-ins to wordprocessing packages, authors only
need to select the appropriate journal template when preparing their article and the list of references and citations to these will be
formatted according to the journal style which is described below.
Reference style
Text:
Indicate references by number(s) in square brackets in line with the text. The actual authors can be referred to, but the reference number(s)
must always be given.
List: Number the references (numbers in square brackets) in the list in the order in which they appear
in the text.
Examples:
Reference to a journal publication:
[1] Van der Geer J, Hanraads JAJ, Lupton RA. The art
of writing a scientific article. J Sci Commun 2010;163:51–9.
Reference to a book:
[2] Strunk Jr W, White EB. The elements
of style. 4th ed. New York: Longman; 2000.
Reference to a chapter in an edited book:
[3] Mettam GR, Adams LB. How to prepare
an electronic version of your article. In: Jones BS, Smith RZ, editors. Introduction to the electronic age, New York: E-Publishing Inc;
2009, p. 281–304.
Note shortened form for last page number. e.g., 51–9, and that for more than 6 authors the first 6
should be listed followed by 'et al.' For further details you are referred to 'Uniform Requirements for Manuscripts submitted to Biomedical
Journals' (J Am Med Assoc 1997;277:927–34) (see also
http://www.nlm.nih.gov/bsd/uniform_requirements.html).
Journal abbreviations source
Journal names should be abbreviated according to
Index Medicus journal abbreviations:
http://www.nlm.nih.gov/tsd/serials/lji.html;
List of title word abbreviations:
http://www.issn.org/2-22661-LTWA-online.php;
CAS (Chemical Abstracts Service):
http://www.cas.org/sent.html.
Supplementary material
Elsevier
accepts electronic supplementary material to support and enhance your scientific research. Supplementary files offer the author additional
possibilities to publish supporting applications, movies, animation sequences, high-resolution images, background datasets, sound clips
and more. Supplementary files supplied will be published online alongside the electronic version of your article in Elsevier Web products,
including ScienceDirect:
http://www.sciencedirect.com. In order to ensure that your submitted material is directly usable,
please ensure that data are provided in one of our recommended file formats. Authors should submit the material in electronic format
together with the article and supply a concise and descriptive caption for each file. Video files: please supply 'stills' with your files:
you can choose any frame from the video or make a separate image. These will be used instead of standard icons and will personalize the
link to your supplementary information. For more detailed instructions please visit our artwork instruction pages at
http://www.elsevier.com/artworkinstructions.
Use of the Digital Object Identifier
The Digital Object Identifier
(DOI) may be used to cite and link to electronic documents. The DOI consists of a unique alpha-numeric character string which is assigned
to a document by the publisher upon the initial electronic publication. The assigned DOI never changes. Therefore, it is an ideal medium
for citing a document, particularly 'Articles in press' because they have not yet received their full bibliographic information. The
correct format for citing a DOI is shown as follows (example taken from a document in the journal
Physics Letters B):
doi:10.1016/j.physletb.2010.09.059
When you use the DOI to create URL hyperlinks to documents on the web, the DOIs are guaranteed never to change.
Proofs
One set of page proofs (as PDF files) will be sent by e-mail to the corresponding author (if we do
not have an e-mail address then paper proofs will be sent by post) or, a link will be provided in the e-mail so that authors can download
the files themselves. Elsevier now provides authors with PDF proofs which can be annotated; for this you will need to download Adobe
Reader version 7 (or higher) available free from
http://get.adobe.com/reader. Instructions on how to annotate PDF files
will accompany the proofs (also given online). The exact system requirements are given at the Adobe site:
http://www.adobe.com/products/reader/tech-specs.html.
If you do not wish to use the PDF annotations function, you may list the corrections (including replies to the Query Form) and return
them to Elsevier in an e-mail. Please list your corrections quoting line number. If, for any reason, this is not possible, then mark
the corrections and any other comments (including replies to the Query Form) on a printout of your proof and return by fax, or scan the
pages and e-mail, or by post. Please use this proof only for checking the typesetting, editing, completeness and correctness of the text,
tables and figures. Significant changes to the article as accepted for publication will only be considered at this stage with permission
from the Editor. We will do everything possible to get your article published quickly and accurately – please let us have all your
corrections within 48 hours. It is important to ensure that all corrections are sent back to us in one communication: please check carefully
before replying, as inclusion of any subsequent corrections cannot be guaranteed. Proofreading is solely your responsibility. Note that
Elsevier may proceed with the publication of your article if no response is received.
Offprints
The
corresponding author, at no cost, will be provided with a PDF file of the article via e-mail. For an extra charge, paper offprints can
be ordered via the offprint order form which is sent once the article is accepted for publication. The PDF file is a watermarked version
of the published article and includes a cover sheet with the journal cover image and a disclaimer outlining the terms and conditions
of use.
For inquiries relating to the submission of articles (including
electronic submission) please visit this journal's homepage. Contact details for questions arising after acceptance of an article, especially
those relating to proofs, will be provided by the publisher. You can track accepted articles at
http://www.elsevier.com/trackarticle.
You can also check our Author FAQs (
http://www.elsevier.com/authorFAQ) and/or contact Customer Support via
http://support.elsevier.com.
